Lutein plus Zeaxanthin ( DrugBank: Lutein, Zeaxanthin )


1 disease
IDDisease name (Link within this page)Number of trials
164Oculocutaneous albinism1

164. Oculocutaneous albinism


Clinical trials : 15 Drugs : 57 - (DrugBank : 34) / Drug target genes : 35 - Drug target pathways : 139
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02200263
(ClinicalTrials.gov)
November 201423/7/2014The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With AlbinismA Randomized Placebo-controlled Trial to Investigate the Effect of Lutein and Zeaxanthin Supplementation on Macular Pigment and Visual Function in Albinism - LUtein for VIsion in Albinism (LUVIA)Ocular Albinism (OA);Oculocutaneous Albinism (OCA)Dietary Supplement: Lutein plus Zeaxanthin;Dietary Supplement: PlaceboJohns Hopkins UniversityClark Charitable Foundation Inc.Completed12 YearsN/AAll10N/AUnited States